Exosens Gains 2.24% and Marks +83% Over the Year, Boosted by Strong Results
Exosens shares rise by 2.24% to €66.30 in mid-afternoon trading, in a downward-trending Paris market. The CAC 40 is down 0.8% during the session at 8,049.98 points. Today's increase brings the three-month performance to over 20% and confirms the momentum initiated after the end-of-April quarterly publication.
Technical Rebound Supported After Q1 Publication
Exosens shares are trading at €66.30, above their 50-day moving average (€63.59) and well above their 200-day moving average (€50.00). The stock is approaching the upper Bollinger band set at €69.41, without reaching it. The RSI at 49 remains neutral, indicating an upward movement without excess. The resistance at €72.90, identified several weeks ago, remains the next technical threshold above the current price. Today's movement follows the session on April 27, where the stock had already gained 2.67% following the publication of the first-quarter results.
Trajectory Aligned with 2025 Guidance
The company confirmed at the end of April a 19.7% increase in revenue for the first quarter of 2026, reaching €122.6 million. During the 9M 2025 publication, Exosens aimed for revenue growth in the upper range of 15-20% for the fiscal year, along with an adjusted EBITDA increase in the lower range of 20-25%. The Q1 pace aligns with these goals. Among the opportunities mentioned by the company is the expansion of production capacities, expected to increase by 40% by 2027 to support demand in night vision and drone applications. The stock now shows an 83.66% increase over the year. Next event: the general assembly on May 22, 2026, followed by the half-year results on July 28.
